ATE213158T1 - Pharmazeutische emulsion - Google Patents

Pharmazeutische emulsion

Info

Publication number
ATE213158T1
ATE213158T1 AT95900965T AT95900965T ATE213158T1 AT E213158 T1 ATE213158 T1 AT E213158T1 AT 95900965 T AT95900965 T AT 95900965T AT 95900965 T AT95900965 T AT 95900965T AT E213158 T1 ATE213158 T1 AT E213158T1
Authority
AT
Austria
Prior art keywords
pct
pharmaceutical emulsion
date
sec
pub
Prior art date
Application number
AT95900965T
Other languages
English (en)
Inventor
Kjell Hjalmar Andersson
Eva Kristina Byroed
Anna-Carin Hansson
Margareta Nordlander
Rolf Christer Westerlund
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Application granted granted Critical
Publication of ATE213158T1 publication Critical patent/ATE213158T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
AT95900965T 1993-11-12 1994-11-03 Pharmazeutische emulsion ATE213158T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9303744A SE9303744D0 (sv) 1993-11-12 1993-11-12 Pharmaceutical emulsion
PCT/SE1994/001032 WO1995013066A1 (en) 1993-11-12 1994-11-03 Pharmaceutical emulsion

Publications (1)

Publication Number Publication Date
ATE213158T1 true ATE213158T1 (de) 2002-02-15

Family

ID=20391731

Family Applications (1)

Application Number Title Priority Date Filing Date
AT95900965T ATE213158T1 (de) 1993-11-12 1994-11-03 Pharmazeutische emulsion

Country Status (31)

Country Link
US (1) US5739152A (de)
EP (1) EP0727997B1 (de)
JP (1) JP3759951B2 (de)
KR (1) KR100345627B1 (de)
CN (1) CN1072934C (de)
AT (1) ATE213158T1 (de)
AU (1) AU678650B2 (de)
CA (1) CA2176360C (de)
CZ (1) CZ290772B6 (de)
DE (1) DE69429871T2 (de)
DK (1) DK0727997T3 (de)
EE (1) EE03223B1 (de)
EG (1) EG20764A (de)
ES (1) ES2172572T3 (de)
FI (1) FI116999B (de)
HK (1) HK1013261A1 (de)
HU (1) HU223142B1 (de)
IL (1) IL111345A (de)
IS (1) IS2036B (de)
MY (1) MY121201A (de)
NO (1) NO314877B1 (de)
NZ (1) NZ276197A (de)
PL (1) PL181462B1 (de)
PT (1) PT727997E (de)
RU (1) RU2144358C1 (de)
SA (1) SA94150314B1 (de)
SE (1) SE9303744D0 (de)
SK (1) SK283271B6 (de)
UA (1) UA40633C2 (de)
WO (1) WO1995013066A1 (de)
ZA (1) ZA948180B (de)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030158220A1 (en) * 1997-11-03 2003-08-21 Foss Joseph F. Use of methylnaltrexone and related compounds to treat chronic opioid use side effects
AU764001B2 (en) * 1998-05-29 2003-08-07 Skyepharma Canada Inc. Thermoprotected microparticle compositions and process for terminal steam sterilization thereof
SE9804002D0 (sv) * 1998-11-23 1998-11-23 Astra Ab New manufacturing process
DE10036871A1 (de) 2000-07-28 2002-02-14 Pharmasol Gmbh Dispersionen zur Formulierung wenig oder schwer löslicher Wirkstoffe
IL159119A0 (en) 2001-06-15 2004-05-12 Cornerstone Pharmaceuticals Pharmaceutical and diagnostic compositions containing nanoparticles useful for treating targeted tissues and cells
PT2368553E (pt) * 2003-04-08 2015-03-03 Progenics Pharm Inc Formulações farmacêuticas contendo metilnaltrexona
AR057325A1 (es) 2005-05-25 2007-11-28 Progenics Pharm Inc Sintesis de (s)-n-metilnaltrexona, composiciones farmaceuticas y usos
AR057035A1 (es) * 2005-05-25 2007-11-14 Progenics Pharm Inc SíNTESIS DE (R)-N-METILNALTREXONA, COMPOSICIONES FARMACÉUTICAS Y USOS
TW200817048A (en) * 2006-09-08 2008-04-16 Wyeth Corp Dry powder compound formulations and uses thereof
PE20130480A1 (es) 2007-03-29 2013-05-08 Progenics Pharm Inc Compuestos heterociclicos como antagonistas del receptor opioide periferico
CN101801979A (zh) 2007-03-29 2010-08-11 普罗热尼奇制药公司 (r)-n-溴化甲基纳曲酮的晶体形式及其用途
PT2565195E (pt) 2007-03-29 2015-07-28 Wyeth Llc Antagonistas e receptor opióide periférico e respectivas utilizações
JP5358587B2 (ja) * 2008-02-06 2013-12-04 プロジェニックス・ファーマシューティカルス・インコーポレイテッド （ｒ），（ｒ）−２，２’−ビス−メチルナルトレキソンの製造及び用途
JP2011529879A (ja) 2008-08-01 2011-12-15 ザ メディシンズ カンパニー 医薬組成物およびこれを安定化させる方法
EA021336B1 (ru) * 2008-08-01 2015-05-29 Дзе Медсинз Компани Фармацевтические композиции и способы их получения при низкой концентрации примесей
CA2676881C (en) 2008-09-30 2017-04-25 Wyeth Peripheral opioid receptor antagonists and uses thereof
US9034389B2 (en) 2009-03-11 2015-05-19 Stable Solutions Llc Omega-3 enriched fish oil-in-water parenteral nutrition emulsions
US8993625B2 (en) 2009-03-11 2015-03-31 Stable Solutions Llc Method of mitigating adverse drug events using omega-3 fatty acids as a parenteral therapeutic drug vehicle
WO2010107081A1 (ja) * 2009-03-19 2010-09-23 第一三共株式会社 包装により安定保存された固形製剤
CN101780036B (zh) * 2010-03-30 2011-11-16 武汉武药科技有限公司 丁酸氯维地平脂微球注射液及其制备方法
WO2012051116A1 (en) 2010-10-12 2012-04-19 The Medicines Company Clevidipine emulsion formulations containing antimicrobial agents
US8658676B2 (en) * 2010-10-12 2014-02-25 The Medicines Company Clevidipine emulsion formulations containing antimicrobial agents
CN102531998A (zh) * 2010-12-09 2012-07-04 天津药物研究院 α型多晶型丁酸氯维地平结晶、其制备方法、用途和药物组合物
CN102525918A (zh) * 2010-12-30 2012-07-04 天津药物研究院 一种丁酸氯维地平的脂肪乳注射液及其制备工艺
US20120213855A1 (en) * 2011-02-17 2012-08-23 Cima Labs Inc. Dosage forms for weakly ionizable compounds
CN103781479A (zh) 2011-04-01 2014-05-07 医药公司 用于减轻中风损害的短效二氢吡啶（氯维地平）
CN104105472A (zh) 2011-12-20 2014-10-15 维奥姆生物科学有限公司 用于治疗真菌感染的局部油组合物
TR201807636T4 (tr) 2012-10-26 2018-06-21 Chiesi Farm Spa Kalp yetmezliğinde kan basıncının kontrol edilmesi ve dispnenin azaltılması için yöntemler.
CN103110580B (zh) * 2013-02-20 2014-09-17 北京德立福瑞医药科技有限公司 丁酸氯维地平注射剂
EA201591954A1 (ru) * 2013-04-12 2016-04-29 Вайом Байосайнсиз Пвт. Лтд. Композиция и состав противомикробных средств, способы их получения и способы лечения микробных инфекций
EP3145508B1 (de) 2014-05-19 2023-07-05 Chiesi Farmaceutici S.p.A. Clevidipinnanopartikel und pharmazeutische zusammensetzungen daraus

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3315805A1 (de) * 1983-04-30 1984-11-08 Bayer Ag, 5090 Leverkusen Wirkstoffzubereitungen
DE3339236A1 (de) * 1983-10-28 1985-05-09 Bayer Ag Arzneimittelzubereitung
DE3515335C2 (de) * 1985-04-27 1995-01-26 Bayer Ag Arzneizubereitung enthaltend Dihydropyridine und Verfahren zu ihrer Herstellung
DE4217842A1 (de) * 1992-05-29 1993-12-02 Dietl Hans Calciumantagonisten enthaltende pharmazeutische Zubereitung zur intravenösen und intrakoronaren Applikation sowie Verfahren zu ihrer Herstellung

Also Published As

Publication number Publication date
FI961999A0 (fi) 1996-05-10
SK59796A3 (en) 1996-12-04
EP0727997A1 (de) 1996-08-28
UA40633C2 (uk) 2001-08-15
HU223142B1 (hu) 2004-03-29
HU9601268D0 (en) 1996-07-29
NO961898L (no) 1996-06-25
IS2036B (is) 2005-08-15
SE9303744D0 (sv) 1993-11-12
NO961898D0 (no) 1996-05-10
FI961999A (fi) 1996-05-10
DE69429871D1 (de) 2002-03-21
CN1136774A (zh) 1996-11-27
CA2176360A1 (en) 1995-05-18
CZ133896A3 (en) 1996-09-11
DE69429871T2 (de) 2002-08-22
EE03223B1 (et) 1999-10-15
NZ276197A (en) 1997-04-24
WO1995013066A1 (en) 1995-05-18
CA2176360C (en) 2005-08-23
IL111345A0 (en) 1994-12-29
IS4224A (is) 1995-05-13
MY121201A (en) 2006-01-28
RU2144358C1 (ru) 2000-01-20
PL181462B1 (pl) 2001-07-31
ES2172572T3 (es) 2002-10-01
IL111345A (en) 2000-08-31
FI116999B (fi) 2006-05-15
AU1037195A (en) 1995-05-29
EP0727997B1 (de) 2002-02-13
SA94150314B1 (ar) 2005-06-14
JPH09505045A (ja) 1997-05-20
PT727997E (pt) 2002-07-31
KR100345627B1 (ko) 2003-03-15
HUT74474A (en) 1996-12-30
CN1072934C (zh) 2001-10-17
HK1013261A1 (en) 1999-08-20
SK283271B6 (sk) 2003-04-01
EG20764A (en) 2000-01-31
ZA948180B (en) 1995-05-12
CZ290772B6 (cs) 2002-10-16
AU678650B2 (en) 1997-06-05
DK0727997T3 (da) 2002-04-22
PL314263A1 (en) 1996-09-02
NO314877B1 (no) 2003-06-10
JP3759951B2 (ja) 2006-03-29
US5739152A (en) 1998-04-14

Similar Documents

Publication Publication Date Title
DE69429871T2 (de) Pharmazeutische emulsion
ES2128761T3 (es) Formulacion de tirilazad con cosolvente para administracion parenteral.
NO973730D0 (no) Faste virkestofftilberedninger
IT1285387B1 (it) Dispositivo e procedimento per la somministrazione transdermica mediante elettrotrasporto di fentanil e sufentanil.
ES2145158T3 (es) Nueva formulacion de emulsion.
IT1285398B1 (it) Dispositivo e procedimento per la somministrazione transdermica mediante elettrotrasporto di fentanil e sufentanil.
ES2172600T3 (es) Composicion farmaceutica que comprende lamotrigina.
NO870560L (no) Nytt farmasoeytisk preparat.
DK0866711T3 (da) Anvendelse af 6-methyl-5-oxo-3-thiomorpholinylcarbonyl-L-histidyl-L-prolinamid til fremstilling af et farmaceutisk præparat til modvirkning af sövnapnö
SE9301831D0 (sv) Pharmaceutical compositions
DK0850225T3 (da) Mellemprodukt til fremstilling af en farmaceutisk aktiv forbindelse

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification